Furthermore, ERG dependably and intensely highlighted endothelial cells in CNS tumors (Figure 2b, Figure 3b, Figure 4b, Figure 5b, Figure 6b), providing solid evidence that ERG is a more robust endothelial marker than CD31 and CD34 are. This evidence concerns the gene ERG and central nervous system neoplasm.